标题 |
Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing recurrent cervical cancer after progression on platinum-based treatment-a single-arm, multicenter, open-label, phase Ⅱ clinical study
disitamab vedotin治疗铂类药物治疗进展后表达HER2的复发性宫颈癌的有效性和安全性评估——一项单臂、多中心、开放标签、Ⅱ期临床研究
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | Lingying W,Guiling L.342 Evaluation of the effectiveness and safety of disitamab vedotin for HER2-expressing recurrent cervical cancer after progression on platinum-based treatment-a single-arm, multicenter, open-label, phase Ⅱ clinical study[J]. Int J Gynecologic Cancer,2024. 34(Suppl 1):A6. |
求助人 | |
下载 |